---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-030718"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:15:13.223455+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharma increases authorized shares to 180M after shareholder approval

## Summary
- Authorized common shares increased from 120M to 180M (50% increase); amendment effective June 20, 2024.
- All ten director nominees elected; highest vote totals over 71M 'for' votes.
- Ratification of EisnerAmper as independent auditor for FY 2024 approved by ~99.9% of votes cast.
- Non-binding advisory vote on named executive officer compensation passed with ~98.4% of votes cast.
- Voter turnout approximately 87.95% of outstanding shares.

## SEC filing metadata
- accession: 0001140361-24-030718
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/0001140361-24-030718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/ef20031374_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-030718
- JSON: https://secwatch.observer/filing/0001140361-24-030718.json
- Plain text: https://secwatch.observer/filing/0001140361-24-030718.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.